| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transcription elongation factor A N-terminal and central domain containing | 5.2E-02 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||||
|
C-reactive protein pseudogene 1 |
|
group | 0.010 | None | 1.000 | 1 | 1 | 2013 | 2013 | |||||||||||
|
relaxin family peptide/INSL5 receptor 4 | 6.0E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||||
|
oxidative stress responsive serine rich 1 | 2.9E-03 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||||
|
preeclampsia/eclampsia 1 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | |||||||||||
|
Nedd4 family interacting protein 2 | 0.53 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||||
|
haloacid dehalogenase like hydrolase domain containing 2 | 3.9E-06 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
group | 0.600 | None | 1.000 | 59 | 0 | 1998 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
group | 0.470 | None | 0.875 | 7 | 1 | 2012 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.400 | None | 0.970 | 63 | 3 | 1999 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
group | 0.100 | None | 1.000 | 76 | 5 | 1997 | 2020 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
group | 0.600 | None | 0.964 | 22 | 1 | 1994 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
group | 0.300 | None | 1.000 | 19 | 0 | 2008 | 2019 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
group | 0.600 | None | 1.000 | 32 | 3 | 1996 | 2020 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 2010 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.530 | None | 1.000 | 3 | 0 | 1998 | 2017 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.070 | None | 0.857 | 7 | 0 | 2009 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
group | 0.360 | None | 1.000 | 6 | 0 | 2005 | 2020 | ||||||||
|
C-reactive protein | 0.299 | 0.962 | 3.7E-03 |
|
group | 0.600 | None | 0.944 | 98 | 0 | 2003 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.230 | None | 1.000 | 3 | 0 | 2005 | 2018 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 2009 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
group | 0.600 | None | 1.000 | 23 | 1 | 2004 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
group | 0.320 | None | 1.000 | 2 | 0 | 2004 | 2017 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
group | 0.050 | None | 1.000 | 5 | 1 | 2015 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.250 | None | 1.000 | 5 | 0 | 2004 | 2018 |